Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Crane NXT, Co. Director's Dealing 2019

Feb 7, 2019

31213_dirs_2019-02-07_2ccacab9-f2a9-4108-9412-2d9e3f50e565.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CRANE CO /DE/ (CR)
CIK: 0000025445
Period of Report: 2019-02-06

Reporting Person: Lavish James A. (VP, CBS, People & Performance)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-06 CRANE CO. COMMON, PAR VALUE $1.00 M 2663 $58.47 Acquired 23527 Direct
2019-02-06 CRANE CO. COMMON, PAR VALUE $1.00 S 2663 $82.8978 Disposed 20864 Direct
2019-02-06 CRANE CO. COMMON, PAR VALUE $1.00 M 5368 $43.57 Acquired 26232 Direct
2019-02-06 CRANE CO. COMMON, PAR VALUE $1.00 S 5368 $82.8978 Disposed 20864 Direct
2019-02-06 CRANE CO. COMMON, PAR VALUE $1.00 M 2865 $73.90 Acquired 23729 Direct
2019-02-06 CRANE CO. COMMON, PAR VALUE $1.00 S 2865 $82.8978 Disposed 20864 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-06 Employee Stock Option (Right to Buy) $58.47 M 2663 Disposed 2025-01-26 CRANE CO. COMMON, PAR VALUE $1.00 (2663.0) Direct
2019-02-06 Employee Stock Option (Right to Buy) $43.57 M 5368 Disposed 2026-01-25 CRANE CO. COMMON, PAR VALUE $1.00 (5368.0) Direct
2019-02-06 Employee Stock Option (Right to Buy) $73.9 M 2865 Disposed 2027-01-30 CRANE CO. COMMON, PAR VALUE $1.00 (2865.0) Direct

Footnotes

F1: Concurrent sale of shares resulting from an exercise of options granted on 1/26/2015 and expiring on 1/26/2025.

F2: Weighted average price at which shares were sold in multiple same-day transactions at prices ranging from $82.7500 to $83.0250. The reporting person undertakes to provide, upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Concurrent sale of shares resulting from an exercise of options granted on 1/25/2016 and expiring on 1/25/2026.

F4: Concurrent sale of shares resulting from an exercise of options granted on 1/30/2017 and expiring on 1/30/2027.

F5: This option vested 25% on the first, 50% on the second, 75% on the third and 100% on the fourth anniversary of the grant date (01/26/2015).

F6: This option vested 25% on the first, 50% on the second and 75% on the third anniversary of the grant date (01/25/2016). The remaining 25% will vest on the fourth anniversary of the grant date.

F7: This option vested 25% on the first and 50% on the second anniversary of the grant date (01/30/2017). The remaining 50% will vest on the third and fourth anniversary of the grant date.